News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
623,684 Results
Type
Article (23654)
Company Profile (175)
Press Release (599158)
Multimedia
Podcasts (25)
Webinars (12)
Section
Business (199311)
Career Advice (809)
Deals (30082)
Drug Delivery (76)
Drug Development (67388)
Employer Resources (52)
FDA (14358)
Job Trends (11642)
News (292601)
Policy (25094)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (5)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1815)
Accelerated approval (45)
ADA (31)
Adcomms (10)
Allergies (160)
Alliances (43179)
ALS (162)
Alzheimer's disease (1485)
Antibody-drug conjugate (ADC) (446)
Approvals (15118)
Artificial intelligence (664)
ASCO (242)
Autoimmune disease (360)
Automation (64)
Bankruptcy (283)
Belgium (1)
Best Places to Work (9588)
BIO (55)
Biologics (12)
BIOSECURE Act (5)
Biosimilars (183)
BioSpace Insights (72)
Biotechnology (117)
Bispecific (1)
Bladder cancer (193)
Brain cancer (62)
Breast cancer (699)
Cancer (5432)
Cardiovascular disease (372)
Career advice (670)
Career pathing (16)
CAR-T (299)
CDC (13)
CDMO (62)
Celiac Disease (1)
Cell therapy (813)
Cervical cancer (47)
Clinical research (60429)
Collaboration (1956)
Commercialization (7)
Compensation (1548)
Complete response letters (49)
COVID-19 (1709)
CRISPR (108)
C-suite (1087)
Cystic fibrosis (131)
Data (8047)
Decentralized trials (3)
Denatured (14)
Depression (143)
Dermatology (97)
Diabetes (514)
Diagnostics (5957)
Digital health (64)
Diversity (8)
Diversity, equity & inclusion (18)
Drug discovery (305)
Drug pricing (78)
Drug shortages (8)
Duchenne muscular dystrophy (209)
Earnings (82134)
Editorial (21)
Employer branding (2)
Employer resources (51)
Events (105500)
Executive appointments (929)
FDA (18192)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (28)
Funding (1518)
Gene editing (216)
Generative AI (48)
Gene therapy (566)
GLP-1 (553)
Government (2509)
Grass and pollen (3)
Guidances (365)
Healthcare (14842)
Hematology (152)
HIV (76)
Huntington's disease (32)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (98)
Immunology and inflammation (209)
Immuno-oncology (91)
Indications (220)
Infectious disease (1993)
Inflammatory bowel disease (181)
Inflation Reduction Act (8)
Influenza (120)
Intellectual property (300)
Interviews (108)
IPO (14098)
IRA (18)
Job creations (2493)
Job search strategy (593)
JPM (21)
Kidney cancer (19)
Labor market (12)
Layoffs (154)
Leadership (13)
Legal (6153)
Licensing (23)
Liver cancer (76)
Longevity (34)
Lung cancer (748)
Lymphoma (428)
Machine learning (53)
Management (20)
Manufacturing (948)
Marketing (11)
MASH (171)
Medical affairs (2)
Medical device (13149)
Medtech (13397)
Mergers & acquisitions (17266)
Metabolic disorders (1108)
mRNA (151)
Multiple sclerosis (191)
Multispecific (1)
NASH (7)
Netherlands (1)
Neurodegenerative disease (365)
Neuropsychiatric disorders (76)
Neuroscience (2882)
Neurotech (1)
NextGen: Class of 2026 (4952)
Non-profit (2324)
Now hiring (19)
Obesity (385)
Opinion (162)
Ovarian cancer (217)
Pain (263)
Pancreatic cancer (278)
Parkinson's disease (324)
Partnered (30)
Patents (612)
Patient recruitment (734)
Patient selection (1)
Peanut (62)
People (49978)
Peptides (3)
Pharmaceutical (37)
Pharmacy benefit managers (22)
Phase 1 (19315)
Phase 2 (26560)
Phase 3 (19101)
Pipeline (10216)
Policy (132)
Postmarket research (2066)
Preclinical (8326)
Press Release (50)
Prostate cancer (265)
Psychedelics (33)
Radiopharmaceuticals (271)
Rare diseases (920)
Real estate (4244)
Recruiting (20)
Regenerative medicine (1)
Regulatory (21352)
Reports (30)
Research institute (1777)
Resumes & cover letters (143)
Rett syndrome (47)
RNA editing (11)
RSV (65)
Schizophrenia (152)
Series A (265)
Series B (196)
Service/supplier (6)
Sickle cell disease (91)
Special edition (5)
Spinal muscular atrophy (136)
Sponsored (38)
Startups (2915)
State (1)
Stomach cancer (10)
Supply chain (90)
Tariffs (17)
The Weekly (11)
Vaccines (701)
Venture capital (64)
Weight loss (178)
Women's health (127)
Worklife (3)
Date
Today (126)
Last 7 days (537)
Last 30 days (1928)
Last 365 days (25443)
2026 (18026)
2025 (25094)
2024 (29306)
2023 (33664)
2022 (43364)
2021 (47073)
2020 (44515)
2019 (35403)
2018 (26629)
2017 (25962)
2016 (25114)
2015 (31502)
2014 (26851)
2013 (22766)
2012 (24823)
2011 (25371)
2010 (25214)
Location
Africa (489)
Alabama (91)
Alaska (4)
Arizona (376)
Arkansas (14)
Asia (29643)
Australia (4119)
California (13815)
Canada (3720)
China (1187)
Colorado (607)
Connecticut (552)
Delaware (325)
Europe (57340)
Florida (2131)
Georgia (463)
Hawaii (4)
Idaho (59)
Illinois (1010)
India (88)
Indiana (597)
Iowa (22)
Japan (563)
Kansas (123)
Kentucky (47)
Louisiana (41)
Maine (40)
Maryland (1515)
Massachusetts (9640)
Michigan (370)
Minnesota (745)
Mississippi (6)
Missouri (145)
Montana (30)
Nebraska (21)
Nevada (168)
New Hampshire (75)
New Jersey (3491)
New Mexico (23)
New York (3579)
North Carolina (1599)
North Dakota (8)
Northern California (7016)
Ohio (400)
Oklahoma (24)
Oregon (32)
Pennsylvania (2598)
Puerto Rico (25)
Rhode Island (41)
South America (714)
South Carolina (86)
South Dakota (2)
Southern California (5616)
Tennessee (196)
Texas (2262)
United States (47691)
Utah (423)
Vermont (2)
Virginia (282)
Washington D.C. (50)
Washington State (1148)
West Virginia (2)
Wisconsin (121)
Wyoming (1)
623,684 Results for "repro med systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Three New Independent Members Join Orano Med’s Governing Board
July 9, 2026
·
3 min read
Press Releases
Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
· Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of MetrioPharm AG. · With more than 800 peer-reviewed publications and various prestigious awards, Prof. Braun is internationally recognized as a leading expert in the field of modern clinical and academic rheumatology.
May 26, 2026
·
1 min read
Press Releases
Orano Med Provides Half-Year Progress Report and Business Outlook
July 31, 2026
·
7 min read
Press Releases
The European Investment Bank Grants Orano a Loan of €125 Million to Finance Orano Med’s Innovations and Industrial Infrastructure
July 1, 2026
·
5 min read
Press Releases
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
June 5, 2026
·
13 min read
Press Releases
Gravity 360, Parent Company of Gravity Diagnostics, Acquires Med-Lake Laboratory, Expanding Its Healthcare Platform Across the Southern United States
August 25, 2026
·
5 min read
Press Releases
TempraMed Launches New Product “VIVI Med(TM),” Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional channel
January 23, 2026
·
6 min read
FDA
Trump’s FDA pick Overton good for psychedelics, new pain meds but bad for vaccines: Analysts
If confirmed by the Senate, Heidi Overton—officially revealed Wednesday as President Donald Trump’s choice for FDA commissioner—is expected to be a boon for developers of psychedelic therapeutics and non-opioid pain drugs, but could tow the party line on vaccines.
August 19, 2026
·
3 min read
·
Heather McKenzie
Press Releases
PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants
July 29, 2026
·
4 min read
Press Releases
LSL PHARMA GROUP PROVIDES UPDATE ON STERI-MED PHARMA MANUFACTURING OPERATIONS AND GRANTS COMPENSATION STOCK OPTIONS
July 6, 2026
·
4 min read
1 of 62,369
Next
